Saving changes...

Done

Error

Practical approaches to targeting the tumor microenvironment

Practical approaches to targeting the tumor microenvironment

Practical approaches to targeting the tumor microenvironment

Veterinary Cancer Society
Veterinary Cancer Society
on behalf of Missouri Veterinary Medical Association

$FREE $ FREE $ FREE

$ FREE $ FREE $ FREE
$ 12.50 $ 12.50 $ 12.50
Normal Price: FREE $12.50

Review:

Launch date: 29 Oct 2015

Expiry Date:

Last updated: 07 Nov 2017

Reference: 161528

Exam is embedded in the course
No preview available
No Exam Available

Latest User Comments

I would like to...

Course Availability

This course is only available to trainees days after purchase. It would need to be repurchased by the trainee if not completed in the allotted time period. This course is no longer available. You will need to repurchase if you wish to take the course again.

Description

Practical approaches to targeting the tumor microenvironment The primary goals of this talk are to illustrate the negative impact of the tumor microenvironment on anti-cancer therapies and to discuss therapeutic approaches to overcoming tumor-induced immune suppression. The key players of the antitumor immune response will be introduced with a focus on regulatory T cells (Treg), myeloid derived suppressor cells (MDSCs) and tumor-associated macrophages (TAMs). Practical strategies to target these important cell populations will then be discussed including metronomic chemotherapy, tyrosine kinase inhibitors and novel drugs.

Objectives

Learning Objectives:
• Identify the key subsets of immune cells that facilitate tumor-induced immune suppression and what is meant by the “tumor microenvironment”
• Give examples of chemotherapy drugs that may be able to improve the patient’s immune response to cancer and discuss their main immunomodulatory effects
Veterinary Cancer Society

Author Information Play Video Bio

Veterinary Cancer Society
on behalf of Missouri Veterinary Medical Association

Dr. Barbara Biller is a DVM, MS, PhD, Diplomate ACVIM (Oncology); Dr. Biller obtained her DVM degree from the University of Wisconsin-Madison in 1993. She completed a rotating internship in small animal medicine and surgery at Colorado State University in 1994 and then a residency in medical oncology at the University of Illinois with board certification in oncology in 1997. After several years in private practice as an oncologist in the Denver area, Dr. Biller pursued and completed a PhD in Immunology at Colorado State University in 2007. She is currently an Associate Professor of Oncology at Colorado State University. Her research interests include the immunomodulatory effects of chemotherapy and application of immunotherapies to veterinary cancer patients.

Current Accreditations

This course has been certified by or provided by the following Certified Organization/s:

  • Missouri Veterinary Medical Association
  • 1.00 Hours -
    Exam Attempts: 3
    -
    Exam Pass Rate: 50

Faculty and Disclosures

Additional Contributors

Conflicts Declared

Conflicts of Interest declaration by Author:

null

User Reviews (0)

Go Back

Loading...


Saving changes...

Done

Error